fda and tirzepatide Wins Approval for Weight Loss FDA's tirzepatide decision creates uncertainty

For the SURPASS-CVOT emulation (tirzepatide vs dulaglutide), the hazard ratio for MACE was 0.83 (95% CI, 0.691.01) compared with 0.92 (95% CI, 0.831.01) in the trial, satisfying all concordance criteria

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options

Safety, Pharmacology, and Regulatory Science : Studying how AOD 9604 is absorbed, distributed, metabolized, and excreted in the body, as well as comparing its safety profile with that of full-length growth hormone

Uplifts pitch to LPs is built around what it calls its 5-5-5 Framework. The firm starts with five services sectorslegal services, financial services, knowledge and talent solutions, technical trades and industrial servicesthen looks for narrow niches where a fragmented market and a repeatable business model give it room to build a larger platform

Court challenges & 2026 status A federal district court denied their preliminary injunction on March 5, 2025